| 1 | [SID51090317] | Active | IC50 | 0.791 | Dose response counterscreen for EBI2 assay utilizing the enzyme, b-galactosidase [AID652193, Type: confirmatory] | Beta-galactosidase [gi:75404427] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC50 | 0.791 [uM] | | BioAssay | Dose response counterscreen for EBI2 assay utilizing the enzyme, b-galactosidase | | AID | 652193 | | BioAssay type | confirmatory | | Target | Beta-galactosidase [gi:75404427] | | PubMed | | | Data Table |  |
|
| 2 | [SID51090317] | Active | EC50 | 1.59 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | EC50 | 1.59 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID51090317] | Active | Potency | 11.6891 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | Potency | 11.6891 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID51090317] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID51090317] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID51090317] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID51090317] | Active | CC50 | 40 | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Sensitize Mycobacterium Tuberculosis to Beta-Lactam Antibiotics [AID434958, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | CC50 | 40 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Sensitize Mycobacterium Tuberculosis to Beta-Lactam Antibiotics | | AID | 434958 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID51090317] | Active | IC90 | 100 | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics [AID434955, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC90 | 100 [uM] | | BioAssay | Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics | | AID | 434955 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID51090317] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID51090317] | Active | | | A CPE Based HTS Assay for Antiviral Drug Screening Against Dengue Virus [AID540333, Type: screening] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | A CPE Based HTS Assay for Antiviral Drug Screening Against Dengue Virus | | AID | 540333 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID51090317] | Active | | | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2766 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 12 | [SID51090317] | Active | | | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2766, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2766 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 13 | [SID51090317] | Active | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 14 | [SID51090317] | Active | | | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay [AID2521, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2521 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 15 | [SID51090317] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 16 | [SID51090317] | Active | | | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay [AID493098, Type: screening] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay | | AID | 493098 | | BioAssay type | screening | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 17 | [SID51090317] | Active | | | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651636, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651636 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 18 | [SID51090317] | Active | | | Single concentration confirmation of uHTS hits from a small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay [AID651997, Type: screening] | GPR183 gene product [Homo sapiens] [gi:4826706] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits from a small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay | | AID | 651997 | | BioAssay type | screening | | Target | GPR183 gene product [Homo sapiens] [gi:4826706] | | PubMed | | | Data Table |  |
|
| 19 | [SID51090317] | Active | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 20 | [SID51090317] | Active | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 21 | [SID51090317] | Active | | | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504634, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504634 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 22 | [SID51090317] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 23 | [SID51090317] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 24 | [SID51090317] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 25 | [SID51090317] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 26 | [SID51090317] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 27 | [SID51090317] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 28 | [SID51090317] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 29 | [SID51090317] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504357, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504357 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 30 | [SID51090317] | Active | | | Single concentration validation of small molecule antagonists of the EBI2 receptor via a luminescent beta-galactosidase assay [AID652176, Type: screening] | Beta-galactosidase [gi:75404427] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | Single concentration validation of small molecule antagonists of the EBI2 receptor via a luminescent beta-galactosidase assay | | AID | 652176 | | BioAssay type | screening | | Target | Beta-galactosidase [gi:75404427] | | PubMed | | | Data Table |  |
|
| 31 | [SID51090317] | Active | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_1, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 32 | [SID51090317] | Active | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_1, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 33 | [SID51090317] | Active | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 34 | [SID51090317] | Active | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 35 | [SID51090317] | Active | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_5, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 36 | [SID51090317] | Active | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_5, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 37 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_6, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 38 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_6, Type: confirmatory] | CCR6 gene product [Homo sapiens] [gi:37187860] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CCR6 gene product [Homo sapiens] [gi:37187860] | | PubMed | | | Data Table |  |
|
| 39 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_9, Type: confirmatory] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 40 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_9, Type: confirmatory] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 41 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_2, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 42 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_2, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 43 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_3, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 44 | [SID51090317] | Unspecified | IC50 | | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129_3, Type: confirmatory] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 45 | [SID51090317] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID51090317] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID51090317] | Inactive | Potency | 0.5012 | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy [AID624291, Type: confirmatory] | Glycoprotein hormones alpha chain [gi:121312] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Inactive | | Potency | 0.5012 [uM] | | BioAssay | qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy | | AID | 624291 | | BioAssay type | confirmatory | | Target | Glycoprotein hormones alpha chain [gi:121312] | | PubMed | | | Data Table |  |
|
| 48 | [SID51090317] | Inactive | Potency | 15.8489 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Inactive | | Potency | 15.8489 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 49 | [SID51090317] | Inactive | IC50 | 20 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129, Type: confirmatory] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 50 | [SID51090317] | Inactive | IC50 | 20 | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay [AID624129, Type: confirmatory] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51090317 | | CID | 24892599 | | Outcome | Inactive | | IC50 | 20 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule antagonists of the CXCR6 receptor in a screening assay | | AID | 624129 | | BioAssay type | confirmatory | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|